Author

J. Singhal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Ranganathan· 3 shared M. Marothia· 3 shared S. Singh· 3 shared A. Chaurasiya· 2 shared A. K. Kahlon· 2 shared N. Singh· 2 shared P. Joshi· 2 shared P. Srivastava· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. Ranganathan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Host inducible-HSP70A1A is an irresistible drug target to combat SARS-CoV-2 infection and pathogenesis

P. Joshi, S. Garg, S. Mani, K. Jakhar, M. Marothia, R. Shoaib, S. Biswas, J. Singhal, A. Behl, A. K. Kahlon, M. Shevtsov, P. Garg, S. Singh, A. Ranganathan

This study shows that inhibiting host Hsp70 reduces SARS-CoV-2 infection more effectively than Remdesivir by blocking viral entry and autophagy.

bioRxiv · May 5, 2023 · PreprintMicrobiology

Identification of merozoite secreted repertoire and immuno-pharmacological inhibition of a novel host-parasite interaction to block malarial infection

N. Singh, A. Munjal, G. Kunari, S. Kaushik, A. K. Kahlon, S. Gupta, A. Chaurasiya, Z.-e.- Anam, M. k. Maurya, P. Srivastava, J. Singhal, M. Marothia, P. Joshi, R. Jain, D. A. B. Rex, , S. Singh

This study identifies the secretory repertoire of Plasmodium merozoites and discovers a peptide that disrupts a key host-parasite interaction, blocking malarial infection.

bioRxiv · Apr 15, 2023 · PreprintMicrobiology

Targeting the artemisinin resistant malaria by repositioning of the anti-Hepatitis C Virus drug Alisporivir

A. Chaurasiya, S. Garg, Z. e. Anam, G. Kumari, N. Joshi, J. Kumari, J. Singhal, N. Singh, S. Kaushik, A. Kaur, n. Dubey, P. Srivastava, M. Marothia, M. Kumar, G. Das, , A. Ranganathan

This study repositions Alisporivir, an anti-Hepatitis C drug, as a potential treatment for artemisinin-resistant malaria by targeting PfCyP-19B, which is overexpressed in resistant parasites.

bioRxiv · Jan 8, 2021 · PreprintMicrobiology